当前位置: X-MOL 学术Lancet Diabetes Endocrinol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies
The Lancet Diabetes & Endocrinology ( IF 44.0 ) Pub Date : 2024-09-23 , DOI: 10.1016/s2213-8587(24)00201-8
Giulia Ferrannini PhD, Prof Jaakko Tuomilehto PhD, Prof Guy De Backer PhD, Prof Kornelia Kotseva PhD, Linda Mellbin PhD, Prof Oliver Schnell PhD, Prof David Wood PhD, Prof Dirk De Bacquer PhD, Prof Lars Rydén PhD

Glucose perturbations can be detected by fasting plasma glucose (FPG), HbA1c, and the oral glucose tolerance test (OGTT). The highest yield is provided by OGTT. HbA1c is considered more practical. We compare the diagnostic and predictive performance of these glycaemic indicators based on combined data from the EUROASPIRE IV (EAIV) and V (EAV) studies.

中文翻译:


冠状动脉疾病患者的血糖异常筛查及其预后影响:EUROASPIRE IV 和 V 队列研究的经验



葡萄糖扰动可通过空腹血糖 (FPG)、HbA1c 和口服葡萄糖耐量试验 (OGTT) 检测。OGTT 提供最高产量。HbA1c 被认为更实用。我们根据 EUROASPIRE IV (EAIV) 和 V (EAV) 研究的综合数据比较了这些血糖指标的诊断和预测性能。
更新日期:2024-09-23
down
wechat
bug